Report cover image

Global Markets and Manufacturing Technologies for Protein Drugs

Publisher BCC Research
Published Apr 30, 2025
Length 162 Pages
SKU # WA20022073

Description

Report Scope

The report analyzes trends in the global market for protein drugs and manufacturing technologies. The report includes global revenue ($ millions) for the base year of 2023 and estimated data for the forecast period of 2024 through 2029. The market is segmented by product type/subtype, manufacturing technology and region. The regions covered are North America, Europe, Asia-Pacific and the Rest of the World, focusing on major countries in these regions.

The report focuses on the trends and challenges that affect the market and the vendor landscape. It analyzes environmental, social, and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, which provides the rankings and market shares of leading companies in the protein drug market. It also has a section of company profiles that shows financials, product portfolios and recent developments.

Report Includes
  • 79 data tables and 57 additional tables
  • An analysis of the global markets for protein drugs and their manufacturing technologies
  • Analyses of the global market trends, with revenue data for 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
  • Estimates of the size of and revenue prospects for the global market, along with a market share analysis by type of protein drug, manufacturing technology, and region
  • Facts and figures pertaining to the market dynamics, technological advances, regulations, and the impact of macroeconomic factors
  • Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
  • Analysis of the advances in manufacturing technologies, disease prevalence trends, new products , and the impact of biosimilars entering the market for protein drugs
  • An analysis of patents and significant patent grants
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Profiles of leading companies, including AbbVie Inc., Bristol Myer Squibb, Merck & Co., Novo Nordisk S/A, Sanofi, and Roche


Companies Mentioned

Abbvie Inc.
Amgen Inc.
Astrazeneca
Bayer Ag
Bristol-myers Squibb Co.
F. Hoffmann-la Roche Ltd.
Johnson & Johnson Services Inc.
Lilly
Merck & Co. Inc.
Novartis Ag
Novo Nordisk A/S
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Sanofi
Takeda Pharmaceutical Co. Ltd.

Table of Contents

162 Pages
Chapter 1 Executive Summary
Market Outlook
Scope Of Report
Market Summary
Chapter 2 Market Overview
Current And Future Market Overview
Technology Background
Pharmacological Classification Of Therapeutic Proteins
Protein Therapeutics With Enzymatic Or Regulatory Activity
Protein Therapeutics With Special Targeting Activity
Protein Vaccines
Characteristics Of Therapeutic Proteins
Macroeconomic Factors
Porter’s Five Forces Analysis
Potential For New Entrants
Bargaining Power Of Suppliers
Bargaining Power Of Buyers
Threat Of Substitute Products Or Services
Competition In The Industry
Supply Chain Analysis
R&D
Manufacturing
Packaging
Wholesale Distributors And Repackagers
Pharmacies/Hospitals
Dispensed To Consumers
Chapter 3 Market Dynamics
Global Market Dynamics
Market Drivers
Advances In Manufacturing Technologies
Continuous Product Launches
Increasing Incidence Of Cancer
Market Restraints
High Costs Of Protein Drugs
Complex Regulatory Procedures
Market Challenges
Patent Expiration And Loss Of Exclusivity
Protein Drugs Stability And Delivery
Market Opportunities
Increasing Number Of Approvals For Mabs
Licensing And Collaboration Agreements
Chapter 4 Regulatory Landscape
Regulatory Scenario
Price Regulations
Chapter 5 Emerging Technologies
Overview
Emerging Technologies In Protein Drugs Market
Bispecific Antibodies And Multi-specific Antibodies
Antibody-drug Conjugates
Antibody Fusion Proteins
Ai In The Protein Drug Market
Chapter 6 Market Segment Analysis
Overview
Segmentation Breakdown
Global Market For Protein Drugs, By Type
Mabs
Peptide Hormones
Vaccines
Blood Factors
Cytokines
Therapeutic Enzymes
Peptide Antibiotics
Fusion Proteins
Global Market For Protein Drugs, By Manufacturing Technology
Cell Culture
Microbial Fermentation
Natural Source
Embryonated Egg
Chemical Synthesis
Transgenics
Market Breakdown By Region
Global Market For Protein Drugs, By Region
North America
Europe
Asia-pacific
Rest Of The World
Chapter 7 Competitive Intelligence
Industry Structure
Leading Protein Drugs, 2023
Market Share Analysis
Mabs
Peptide Hormones
Strategic Analysis
Acquisitions
Product Approvals
Agreements And Partnerships
Other Strategies
Chapter 8 Sustainability In The Protein Drug Market: Esg Perspective
Sustainability In The Protein Drug Industry
Esg Risk Ratings: Understanding The Data
Esg Performance Analysis
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks
Chapter 9 Appendix
Methodology
Abbreviations
References
Company Profiles
Abbvie Inc.
Amgen Inc.
Astrazeneca
Bayer Ag
Bristol-myers Squibb Co.
F. Hoffmann-la Roche Ltd.
Johnson & Johnson Services Inc.
Lilly
Merck & Co. Inc.
Novartis Ag
Novo Nordisk A/S
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Sanofi
Takeda Pharmaceutical Co. Ltd.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us